Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in healthy male subjects

Trial Identifier:	BEX16018
Sponsor:	Sanofi
Start Date:	November 2019
Primary Completion Date:	December 2019
Study Completion Date:	December 2019
Condition:	Multiple Sclerosis (MS)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Nottingham, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.